Innometry (Korea) Performance
| 302430 Stock | KRW 12,140 2,800 29.98% |
Innometry holds a performance score of 13 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.0663, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Innometry's returns are expected to increase less than the market. However, during the bear market, the loss of holding Innometry is expected to be smaller as well. Use Innometry Co standard deviation, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to analyze future returns on Innometry Co.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Innometry Co are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innometry sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Total Cashflows From Investing Activities | -9.6 B |
Innometry |
Innometry Relative Risk vs. Return Landscape
If you would invest 743,000 in Innometry Co on December 20, 2024 and sell it today you would earn a total of 471,000 from holding Innometry Co or generate 63.39% return on investment over 90 days. Innometry Co is generating 1.0376% of daily returns and assumes 6.0855% volatility on return distribution over the 90 days horizon. Simply put, 54% of stocks are less volatile than Innometry, and 80% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Innometry Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innometry's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Innometry Co, and traders can use it to determine the average amount a Innometry's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1705
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 302430 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.09 actual daily | 54 54% of assets are less volatile |
Expected Return
| 1.04 actual daily | 20 80% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Innometry is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innometry by adding it to a well-diversified portfolio.
Innometry Fundamentals Growth
Innometry Stock prices reflect investors' perceptions of the future prospects and financial health of Innometry, and Innometry fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Innometry Stock performance.
| Return On Equity | 3.0 | |||
| Return On Asset | -0.0475 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.19) % | |||
| Current Valuation | 138.2 B | |||
| Shares Outstanding | 4.83 M | |||
| Price To Sales | 2.67 X | |||
| Revenue | 46.47 B | |||
| EBITDA | (3.89 B) | |||
| Cash And Equivalents | 4.97 B | |||
| Total Debt | 222.19 M | |||
| Debt To Equity | 0.01 % | |||
| Cash Flow From Operations | (4.29 B) | |||
| Total Asset | 67.59 B | |||
About Innometry Performance
By analyzing Innometry's fundamental ratios, stakeholders can gain valuable insights into Innometry's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Innometry has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Innometry has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Innometry Co., Ltd. manufactures and sells X-ray inspection systems in South Korea. The company was founded in 2008 and is headquartered in Hwaseong, South Korea. INNOMETRY is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Innometry performance evaluation
Checking the ongoing alerts about Innometry for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Innometry help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Innometry is way too risky over 90 days horizon | |
| Innometry appears to be risky and price may revert if volatility continues | |
| Innometry Co has accumulated about 4.97 B in cash with (4.29 B) of positive cash flow from operations. | |
| Roughly 54.0% of the company shares are owned by insiders or employees |
- Analyzing Innometry's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Innometry's stock is overvalued or undervalued compared to its peers.
- Examining Innometry's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Innometry's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Innometry's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Innometry's stock. These opinions can provide insight into Innometry's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Innometry Stock analysis
When running Innometry's price analysis, check to measure Innometry's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innometry is operating at the current time. Most of Innometry's value examination focuses on studying past and present price action to predict the probability of Innometry's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innometry's price. Additionally, you may evaluate how the addition of Innometry to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stocks Directory Find actively traded stocks across global markets |